98 related articles for article (PubMed ID: 27928660)
1. Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease.
Sørensen SS; Pedersen KM; Weinreich UM; Ehlers L
Appl Health Econ Health Policy; 2017 Jun; 15(3):413-424. PubMed ID: 27928660
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North' cluster-randomised trial.
Witt Udsen F; Lilholt PH; Hejlesen O; Ehlers L
BMJ Open; 2017 May; 7(5):e014616. PubMed ID: 28515193
[TBL] [Abstract][Full Text] [Related]
3. Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease.
Sørensen SS; Jensen MB; Pedersen KM; Ehlers L
Value Health; 2018 Feb; 21(2):239-247. PubMed ID: 29477406
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
[TBL] [Abstract][Full Text] [Related]
5. Economic benefits of self-management education in COPD.
Bourbeau J; Collet JP; Schwartzman K; Ducruet T; Nault D; Bradley C
Chest; 2006 Dec; 130(6):1704-11. PubMed ID: 17166985
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the COPD Patient Management European Trial home-based disease management program.
Bourbeau J; Granados D; Roze S; Durand-Zaleski I; Casan P; Köhler D; Tognella S; Viejo JL; Dal Negro RW; Kessler R
Int J Chron Obstruct Pulmon Dis; 2019; 14():645-657. PubMed ID: 30936689
[TBL] [Abstract][Full Text] [Related]
7. Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data.
Briggs AH; Lozano-Ortega G; Spencer S; Bale G; Spencer MD; Burge PS
Value Health; 2006; 9(4):227-35. PubMed ID: 16903992
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of a group-based exercise program for falls prevention among the older community-dwelling population.
McLean K; Day L; Dalton A
BMC Geriatr; 2015 Mar; 15():33. PubMed ID: 25879871
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure.
Sørensen SS; Storgaard LH; Weinreich UM
Clinicoecon Outcomes Res; 2021; 13():553-564. PubMed ID: 34168472
[TBL] [Abstract][Full Text] [Related]
10. Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France.
Atsou K; Crequit P; Chouaid C; Hejblum G
PLoS One; 2016; 11(6):e0156514. PubMed ID: 27327159
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of total knee replacement in addition to non-surgical treatment: a 2-year outcome from a randomised trial in secondary care in Denmark.
Skou ST; Roos E; Laursen M; Arendt-Nielsen L; Rasmussen S; Simonsen O; Ibsen R; Larsen AT; Kjellberg J
BMJ Open; 2020 Jan; 10(1):e033495. PubMed ID: 31948990
[TBL] [Abstract][Full Text] [Related]
12. Alitretinoin for the treatment of severe chronic hand eczema.
Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of a Community-Based Exercise Programme in COPD Self-Management.
Zwerink M; Effing T; Kerstjens HA; van der Valk P; Brusse-Keizer M; Zielhuis G; van der Palen J
COPD; 2016; 13(2):214-23. PubMed ID: 26623496
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease.
Oba Y
Am J Manag Care; 2009 Feb; 15(2):97-104. PubMed ID: 19284806
[TBL] [Abstract][Full Text] [Related]
15. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.
Hofer F; Achelrod D; Stargardt T
Appl Health Econ Health Policy; 2016 Dec; 14(6):691-701. PubMed ID: 27475635
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
[TBL] [Abstract][Full Text] [Related]
17. The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial.
Burns DK; Wilson EC; Browne P; Olive S; Clark A; Galey P; Dix E; Woodhouse H; Robinson S; Wilson A
Appl Health Econ Health Policy; 2016 Feb; 14(1):105-15. PubMed ID: 26346590
[TBL] [Abstract][Full Text] [Related]
18. Incorporating Household Spillovers in Cost Utility Analysis: A Case Study Using Behavior Change in COPD.
Bhadhuri A; Al-Janabi H; Jowett S; Jolly K
Int J Technol Assess Health Care; 2019 Jan; 35(3):212-220. PubMed ID: 31064563
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
Tunis SL
Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
[TBL] [Abstract][Full Text] [Related]
20. Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.
Atsou K; Chouaid C; Hejblum G
PLoS One; 2011; 6(9):e24870. PubMed ID: 21949774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
